Hi Kluck,There is nothing new about MaxCyte's Flow...

Hi Kluck,

There is nothing new about MaxCyte's Flow Electroporation® technologies being used to manufacture Azer-cel, as it is already in use and won't be used to further improve Azer-cel because it has already been used to improve the manufacturing process of Azer-cel.
Here's a link which explains the technology: Our Flow Electroporation Technology | MaxCyte

The analogy is slightly off because it's more of a rental agreement for those machines rather than a supply agreement, but much like water and electricity, the manufacturing facility can't operate to produce Azer-cel without any of them. I would expect Imugene to have taken over the rental (licencing) agreement for the MaxCyte's Flow Electroporation® machines as much as I'd expect them to take over the access to all the other services required to operate the factory.

Here's an article from 2018 (4 years ago) about the signing of the licencing agreement which Imugene has now taken over:
Precision BioSciences and MaxCyte Enter into Clinical and Commercial License Agreement (prnewswire.com)